Statera Biopharma, Inc. (STAB)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 26, 2026, 2:18 PM EST
Statera Biopharma Revenue
Statera Biopharma had revenue of $670.47K in the quarter ending September 30, 2022, with 183.48% growth. This brings the company's revenue in the last twelve months to $3.69M, up 1,459.14% year-over-year. In the year 2021, Statera Biopharma had annual revenue of $1.49M.
Revenue (ttm)
3.69M
Revenue Growth
+1,459.14%
P/S Ratio
0.00
Revenue / Employee
80.17K
Employees
46
Market Cap
7.26K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 1.49M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionStatera Biopharma News
- 10 months ago - Tivic Health receives two investigational new drug applications from Statera - TheFly
- 1 year ago - Tivic Health acquires exclusive rights to Entolimod from Statera BioPharma - TheFly
- 1 year ago - Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma - Business Wire
- 3 years ago - Statera BioPharma, Biostax reach dispute settlement, amended license agreement - TheFly
- 3 years ago - Statera BioPharma enters LOI for merger with Worksite Labs - TheFly
- 3 years ago - Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs - GlobeNewsWire
- 3 years ago - Statera Biopharma Announces Completion of Application Process to Uplist to the OTCQB(R) Venture Marketplace - Accesswire
- 3 years ago - Statera Biopharma Receives Positive Nasdaq Listing Determination - Accesswire